Aquaporin-4-dependent glymphatic solute transport in the rodent brain
Abstract
The glymphatic system is a brain-wide clearance pathway; its impairment contributes to the accumulation of amyloid-β. Influx of cerebrospinal fluid(CSF) depends upon the expression and perivascular localization of the astroglial water channel aquaporin-4(AQP4). Prompted by a recent failure to find an effect of Aqp4 knock-out(KO) on CSF and interstitial fluid(ISF) tracer transport, five groups re-examined the importance of AQP4 in glymphatic transport. We concur that CSF influx is higher in wildtype mice than in four different Aqp4 KO lines and in one line that lacks perivascular AQP4(Snta1 KO). Meta-analysis of all studies demonstrated a significant decrease in tracer transport in KO mice and rats compared to controls. Meta-regression indicated that anesthesia, age, and tracer delivery explain the opposing results. We also report that intrastriatal injections suppress glymphatic function. This validates the role of AQP4 in accordance with the glymphatic system and shows that invasive procedures should not be utilized.
Data availability
All data generated or analysed during this study are included in the manuscript.
Article and author information
Author details
Funding
National Institutes of Health (NS100366)
- Maiken Nedergaard
Japan Society for the Promotion of Science (18H02606)
- Masato Yasui
Human Frontier Science Program (RGP0036/2014)
- Hajime Hirase
Japan Society for the Promotion of Science (Core-to-Core Program)
- Hajime Hirase
Lundbeckfonden (Visiting Professorship)
- Hajime Hirase
Knut och Alice Wallenbergs Stiftelse (Helse Vet)
- Alexander S Thrane
National Institutes of Health (NS061800)
- Aravind Asokan
National Institutes of Health (AG048769)
- Maiken Nedergaard
National Institutes of Health (AG054456)
- Jeffrey J Iliff
National Institutes of Health (NS099371)
- Aravind Asokan
National Institutes of Health (HL089221)
- Aravind Asokan
National Institutes of Health (NS089709)
- Jeffrey J Iliff
National Institutes of Health (NS078394)
- Maiken Nedergaard
National Institutes of Health (AG048769)
- Maiken Nedergaard
Japan Society for the Promotion of Science (18K14859)
- Hiromu Monai
Japan Society for the Promotion of Science (16H01888)
- Hajime Hirase
Japan Society for the Promotion of Science (18H05150)
- Hajime Hirase
Japan Society for the Promotion of Science (17K19637)
- Yoichiro Abe
Japan Society for the Promotion of Science (16H05134)
- Yoichiro Abe
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: All experiments were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (IACUC-1601106), Wako Animal Experiment Committee, RIKEN (Recombinant DNA experimentation protocol: 2016-038; Animal experimentation protocol: H29-2-227), The University of North Carolina at Chapel Hill Institutional Animal Care and Use Committee (protocol 15-109), the University Committee on Animal Resources of the University of Rochester (protocol 2011-023), and the IACUC of Oregon Health and Science University (protocol IP00000394). All experiments were performed in accordance with the approved guidelines and regulations. All efforts were made to minimize animal suffering and to reduce the number of animals used for the experiments.
Copyright
© 2018, Mestre et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 11,187
- views
-
- 2,042
- downloads
-
- 417
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
Gamma oscillations in brain activity (30–150 Hz) have been studied for over 80 years. Although in the past three decades significant progress has been made to try to understand their functional role, a definitive answer regarding their causal implication in perception, cognition, and behavior still lies ahead of us. Here, we first review the basic neural mechanisms that give rise to gamma oscillations and then focus on two main pillars of exploration. The first pillar examines the major theories regarding their functional role in information processing in the brain, also highlighting critical viewpoints. The second pillar reviews a novel research direction that proposes a therapeutic role for gamma oscillations, namely the gamma entrainment using sensory stimulation (GENUS). We extensively discuss both the positive findings and the issues regarding reproducibility of GENUS. Going beyond the functional and therapeutic role of gamma, we propose a third pillar of exploration, where gamma, generated endogenously by cortical circuits, is essential for maintenance of healthy circuit function. We propose that four classes of interneurons, namely those expressing parvalbumin (PV), vasointestinal peptide (VIP), somatostatin (SST), and nitric oxide synthase (NOS) take advantage of endogenous gamma to perform active vasomotor control that maintains homeostasis in the neuronal tissue. According to this hypothesis, which we call GAMER (GAmma MEdiated ciRcuit maintenance), gamma oscillations act as a ‘servicing’ rhythm that enables efficient translation of neural activity into vascular responses that are essential for optimal neurometabolic processes. GAMER is an extension of GENUS, where endogenous rather than entrained gamma plays a fundamental role. Finally, we propose several critical experiments to test the GAMER hypothesis.
-
- Medicine
- Neuroscience
The advent of midazolam holds profound implications for modern clinical practice. The hypnotic and sedative effects of midazolam afford it broad clinical applicability. However, the specific mechanisms underlying the modulation of altered consciousness by midazolam remain elusive. Herein, using pharmacology, optogenetics, chemogenetics, fiber photometry, and gene knockdown, this in vivo research revealed the role of locus coeruleus (LC)-ventrolateral preoptic nucleus noradrenergic neural circuit in regulating midazolam-induced altered consciousness. This effect was mediated by α1 adrenergic receptors. Moreover, gamma-aminobutyric acid receptor type A (GABAA-R) represents a mechanistically crucial binding site in the LC for midazolam. These findings will provide novel insights into the neural circuit mechanisms underlying the recovery of consciousness after midazolam administration and will help guide the timing of clinical dosing and propose effective intervention targets for timely recovery from midazolam-induced loss of consciousness.